A detailed history of Two Sigma Securities, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 12,173 shares of PBYI stock, worth $36,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,173
Holding current value
$36,640
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.25 - $4.03 $27,389 - $49,057
12,173 New
12,173 $31,000
Q2 2022

Aug 15, 2022

BUY
$1.64 - $3.3 $23,215 - $46,714
14,156 New
14,156 $40,000
Q4 2019

Feb 14, 2020

SELL
$6.5 - $10.73 $67,574 - $111,549
-10,396 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$8.75 - $12.85 $90,965 - $133,588
10,396 New
10,396 $112,000
Q2 2019

Aug 14, 2019

SELL
$12.3 - $35.76 $64,734 - $188,204
-5,263 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$20.77 - $42.37 $109,312 - $222,993
5,263 New
5,263 $204,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $137M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.